3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
申请人:Vacher Bernard
公开号:US20060014827A1
公开(公告)日:2006-01-19
The invention provides compounds of the formula:
wherein (a) is a single or double bond; W is CH, CH
2
, CHCH
3
, CCH
3
, C(CH
3
)
2
, C(CH
2
)
2
or C(CH
2
)
3
, provided that when (a) is a double bond, then W is CH or CCH
3
, and when (a) is a single bond, then W is CH
2
, CHCH
3
, C(CH
3
)
2
, C(CH
2
)
2
or C(CH
2
)
3
; X is CH or N; and Y is H or F, and salts, hydrates, tautomers, pure enantiomers, and enantiomeric mixtures; and a method of treating schizophrenia comprising administering same.
该发明提供了以下结构的化合物:
其中(a)是单键或双键;W是CH、CH2、CHCH3、CCH3、C(CH3)2、C(CH2)2或C(CH2)3,但当(a)是双键时,W为CH或CCH3,当(a)是单键时,W为CH2、CHCH3、C(CH3)2、C(CH2)2或C(CH2)3;X是CH或N;Y是H或F,以及盐、水合物、互变异构体、纯对映体和对映体混合物;以及一种治疗精神分裂症的方法,包括给予同样的化合物。